Video

Adil Harroud, MD

Publish date: February 9, 2018

At the ACTRIMS 2018 Forum, Dr. Harroud describes his investigation of the potential link between age at puberty onset and risk of MS.


 

Recommended Reading

VIDEO: Oral ozanimod shows promise for relapsing MS
MDedge Neurology
Switching RRMS patients to daclizumab beta appears safe
MDedge Neurology
Third course of alemtuzumab can improve MS outcomes
MDedge Neurology
VIDEO: Managing the alemtuzumab paradox
MDedge Neurology
MS: Past, Present, and Future
MDedge Neurology
Rituximab May Provide Greater Benefits Than Other First-Line MS Therapies
MDedge Neurology
MAGNIMS and McDonald Criteria Have Similar Accuracy
MDedge Neurology
Trial of clozapine, risperidone halted in MS
MDedge Neurology
‘Real-world evidence’ used to compare agents for relapsing-remitting MS
MDedge Neurology
VIDEO: Advanced practice providers take on many roles in MS care
MDedge Neurology